Buy, Sell or Hold: Nuvama initiates coverage on Eureka Forbes; Religare Broking positive on REC

Brokerages stay bullish: Nuvama starts Eureka Forbes with Buy (20% upside), Motilal Oswal reaffirms Biocon Buy (13% upside), Religare Broking positive on REC Ltd (22% upside) citing strong growth drivers.